Zalicus discovers and develops innovative therapeutics for patients in need. We believe that our novel product candidates, productive drug discovery platforms, drug development expertise, revenue-generating collaborations and financial resources provide a solid foundation for success.
View Top Employees from ZalicusWebsite | http://www.zalicus.com |
Ticker | NASDAQ:CRXX |
Revenue | $16.4 million |
Employees | 17 (17 on RocketReach) |
Founded | 2000 |
Address | 245 1st St Fl 3, Cambridge, Massachusetts 02142, US |
Phone | (617) 301-7000 |
Technologies |
JavaScript,
HTML,
Cloudflare
+19 more
(view full list)
|
Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering, Health Care, Medical |
Competitors | Aeglea BioTherapeutics, CTI BioPharma, Galecto, Inc., Ocugen, Spero Therapeutics |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325412 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Zalicus employee's phone or email?
The Zalicus annual revenue was $16.4 million in 2024.
Elias Nyberg is the Vice President Regulatory of Zalicus.
17 people are employed at Zalicus.
Zalicus is based in Cambridge, Massachusetts.
The NAICS codes for Zalicus are [32, 3254, 325412, 325, 32541].
The SIC codes for Zalicus are [283, 28].